The Role of Noninvasive Endpoints in Predicting Long-Term Outcomes in Pulmonary Arterial Hypertension.

Authors:
Wronski SL; Mordin M; Kelley K; Anguiano RH; Classi P and 2 more

Journal:
Lung

Publication Year: 2019

DOI:
10.1007/s00408-019-00289-2

PMCID:
PMC7012965

PMID:
31722043

Journal Information

Full Title: Lung

Abbreviation: Lung

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pulmonary Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest Samantha Wronski and Margaret Mordin are employees of RTI Health Solutions. Kim Kelley is business owner of Rx Trusted Advisors, PLLC which works with life science and futurist groups, along with peer to peer learning, pipeline strategy sessions. And additional work advising in high cost pharmacy and medical cases. Previous Director of Pharmacy for BlueCross and BlueShield of Arizona. Groups and organizations I have worked directly or indirectly with or own stock include; Rx Worldwide Meetings, Navigant Life Sciences, Amgen, Novartis, UCB, Gerson Lehrman Group Councel, Lilly, United Therapeutics Corporation, CB Partner, McCann Health, ClearView Health Partners, Parallax Life Sciences, Insmed, Integrated Healthcare Management, Business Talent Group, Evidera, and River West Meeting Associates. Dr. Anguiano is on the speaker’s bureau and advisory board for United Therapeutics. Peter Classi is an employee and minor shareholder in United Therapeutics Corporation. Eric Shen is an employee of United Therapeutics Corporation. Scott Manaker is a Grand Rounds speaker, lecturer, consultant, and expert witness on documentation, coding, billing, and reimbursement to hospitals, physicians, departments, practice groups, professional societies, insurers, and attorneys (defense, plaintiff “qui tam”, US Attorneys General, and the Office of the Inspector General). Consultant to Apnicure, Aetna, Pfizer, Novartis and Johnson & Johnson. Expert witness in workers’ compensation and in medical negligence matters. Chair, Practice Expense Subcommittee of the American Medical Association/Specialty Society Relative Value Update Committee (RUC). Member, Hospital Outpatient Panel, a federal advisory commission to the Center for Medicare/Medicaid Services (CMS) for the Outpatient Hospital Prospective Payment System. Stock held in 3M; and (by spouse) in Pfizer, Johnson & Johnson. Director of ACCP Enterprises, a wholly owned for-profit subsidiary of ACCP. Section Editor (Critical Care), UpToDate. Associate Editor, CHEST Journal. Trustee, National Board for Respiratory Care."

Evidence found in paper:

"Funding United therapeutics supported this research."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025